Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis

PURPOSE: Tocilizumab has shown equivocal outcomes in reducing mortality in COVID-19. The corticosteroids appear to be an affordable alternative to tocilizumab. This study aims to estimate the efficacy of tocilizumab and the corticosteroids particularly dexamethasone and methylprednisolone and to ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Phei Ching, Wong, Kar Loon, Rajah, Retha, Chong, Meng Fei, Chow, Ting Soo, Subramaniam, Sivasangari, Lee, Chong Yew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792140/
https://www.ncbi.nlm.nih.gov/pubmed/35084705
http://dx.doi.org/10.1007/s40199-021-00430-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792140/
https://www.ncbi.nlm.nih.gov/pubmed/35084705
http://dx.doi.org/10.1007/s40199-021-00430-8

Ejemplares similares